Plain-English translation of NCT06603662 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether or — two steroid medications — can help relieve sudden, severe arthritis pain more effectively than ibuprofen alone. You would be treated in an emergency department with one of these medications plus ibuprofen, or with ibuprofen and a placebo, and then monitored to see which approach works best.
Many people come to the emergency department with sudden flare-ups of arthritis pain that don't respond well to standard pain relievers. Researchers want to know if adding a short course of this medication to ibuprofen can provide better and faster pain relief for these patients.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either for 5 days plus ibuprofen, a single dose of plus ibuprofen for 5 days, or placebo plus ibuprofen for 5 days. All participants also take ibuprofen every 8 hours for 5 days. You will be treated in the emergency department and then discharged home with your assigned medication to take as directed.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
United States